Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets close in 5 hours 5 minutes
ALL ORDS
8,144.30
+24.10
(+0.30%)
ASX 200
7,872.80
+21.10
(+0.27%)
AUD/USD
0.6669
-0.0001
(-0.02%)
OIL
79.06
-0.20
(-0.25%)
GOLD
2,424.10
-1.80
(-0.07%)
Bitcoin AUD
105,131.32
-1,655.91
(-1.55%)
ContraVir Pharmaceuticals, Inc. (CTRVP)
Other OTC . Currency in USD
Add to watchlist
-
(-)
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
35,640
35,640
33,269
20,395
11,997
Selling general and administrative
9,618
9,618
10,348
10,008
8,149
Total operating expenses
45,258
45,258
43,618
30,403
20,146
Operating income or loss
-45,258
-45,258
-43,618
-30,403
-20,146
Interest expense
9.465
9.465
10.164
8.859
31.229
Total other income/expenses net
-4,068
-4,068
-1,456
-2,310
-146.05
Income before tax
-49,335
-49,335
-45,084
-32,722
-20,323
Income tax expense
-409.022
-409.022
-2,884
0
30.584
Income from continuing operations
-48,926
-48,926
-42,200
-32,722
-20,354
Net income
-48,926
-48,926
-42,200
-32,722
-20,354
Net income available to common shareholders
-48,926
-48,926
-45,338
-32,722
-20,359
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.